SOD2 and diabetic kidney disease: MaR1 can mitigate DKD through the LGR6—(leucine-rich repeat domain-containing G protein-coupled receptor 6 -) mediated cAMP—(cyclic adenosine 3’,5’—monophosphate-) SOD2 (Mn-SOD) antioxidant pathway [82].